| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:34597818; PMID:35762964 |
| GO:0001547 | Antral ovarian follicle growth | Decreases phenotype | PMID:28013214 |
| GO:0001553 | Luteinization | Affects phenotype | PMID:26161573 |
| GO:0001568 | Blood vessel development | Increases phenotype | PMID:37021957 |
| GO:0001780 | Neutrophil homeostasis | Affects phenotype | PMID:28240277 |
| GO:0001890 | Placenta development | Affects phenotype | PMID:37482143 |
| GO:0002248 | Connective tissue replacement involved in inflammatory response wound healing | Increases phenotype | PMID:29758289 |
| GO:0002381 | Immunoglobulin production involved in immunoglobulin-mediated immune response | Increases phenotype | PMID:29758289 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:27863430; PMID:28240277; PMID:29758289 |
| GO:0003006 | Developmental process involved in reproduction | Affects phenotype | PMID:37788136 |
| GO:0003093 | Regulation of glomerular filtration | Affects phenotype | PMID:32645486 |
| GO:0004691 | Camp-dependent protein kinase activity | Increases phenotype | PMID:33711355 |
| GO:0006085 | Acetyl-coa biosynthetic process | Affects phenotype | PMID:33391822 |
| GO:0006171 | Camp biosynthetic process | Increases phenotype | PMID:37552060 |
| GO:0006473 | Protein acetylation | Increases phenotype | PMID:31423773 |
| GO:0006672 | Ceramide metabolic process | Affects phenotype | PMID:33223173 |
| GO:0006694 | Steroid biosynthetic process | Decreases phenotype | PMID:35762964 |
| GO:0007281 | Germ cell development | Decreases phenotype | PMID:30802670; PMID:37788136 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:30802670; PMID:37364641 |
| GO:0007286 | Spermatid development | Decreases phenotype | PMID:30802670 |
| GO:0007565 | Female pregnancy | Decreases phenotype | PMID:36929940 |
| GO:0007618 | Mating | Decreases phenotype | PMID:30649530 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:34597818 |
| GO:0008219 | Cell death | Increases phenotype | PMID:33711355 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:34428494 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:35739755 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:25445723; PMID:36921846; PMID:30802670 |
| GO:0009566 | Fertilization | Decreases phenotype | PMID:26545148; PMID:33711355 |
| GO:0009790 | Embryo development | Decreases phenotype | PMID:33711355 |
| GO:0010460 | Positive regulation of heart rate | Increases phenotype | PMID:30940551 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:37976928 |
| GO:0010511 | Regulation of phosphatidylinositol biosynthetic process | Affects phenotype | PMID:31577137 |
| GO:0010884 | Positive regulation of lipid storage | Increases phenotype | PMID:29410257 |
| GO:0010906 | Regulation of glucose metabolic process | Affects phenotype | PMID:35739755; PMID:37364641 |
| GO:0016525 | Negative regulation of angiogenesis | Increases phenotype | PMID:37482143 |
| GO:0018108 | Peptidyl-tyrosine phosphorylation | Increases phenotype | PMID:33711355 |
| GO:0019695 | Choline metabolic process | Affects phenotype | PMID:32949613 |
| GO:0030199 | Collagen fibril organization | Decreases phenotype | PMID:29758289 |
| GO:0030728 | Ovulation | Increases phenotype | PMID:33316053 |
| GO:0030850 | Prostate gland development | Decreases phenotype | PMID:30802670; PMID:36921846 |
| GO:0032308 | Positive regulation of prostaglandin secretion | Increases phenotype | PMID:33316053 |
| GO:0033685 | Negative regulation of luteinizing hormone secretion | Increases phenotype | PMID:37812459 |
| GO:0034199 | Activation of protein kinase a activity | Increases phenotype | PMID:37552060 |
| GO:0034255 | Regulation of urea metabolic process | Affects phenotype | PMID:32949613 |
| GO:0034614 | Cellular response to reactive oxygen species | Increases phenotype | PMID:29758289 |
| GO:0035936 | Testosterone secretion | Decreases phenotype | PMID:28013214; PMID:30802670; PMID:31199487 |
| GO:0035938 | Estradiol secretion | Decreases phenotype | PMID:28013214 |
| GO:0035941 | Androstenedione secretion | Decreases phenotype | PMID:28013214 |
| GO:0035943 | Estrone secretion | Decreases phenotype | PMID:28013214 |
| GO:0036211 | Protein modification process | Increases phenotype | PMID:31423773 |
| GO:0042221 | Response to chemical | Increases phenotype | PMID:34428494 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:34597818 |
| GO:0042629 | Mast cell granule | Increases phenotype | PMID:27863430 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:35739755 |
| GO:0042701 | Progesterone secretion | Affects phenotype | PMID:33316053 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:33511402; PMID:35739755; PMID:37364641 |
| GO:0043303 | Mast cell degranulation | Increases phenotype | PMID:28240277; PMID:29758289 |
| GO:0044237 | Cellular metabolic process | Affects phenotype | PMID:31154059; PMID:34697989 |
| GO:0044849 | Estrous cycle | Decreases phenotype | PMID:30649530; PMID:36929940 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:29991372 |
| GO:0045600 | Positive regulation of fat cell differentiation | Increases phenotype | PMID:31546122 |
| GO:0045777 | Positive regulation of blood pressure | Increases phenotype | PMID:30940551 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:33711355 |
| GO:0046322 | Negative regulation of fatty acid oxidation | Increases phenotype | PMID:33391822 |
| GO:0046339 | Diacylglycerol metabolic process | Affects phenotype | PMID:33223173 |
| GO:0046546 | Development of primary male sexual characteristics | Affects phenotype | PMID:36921846 |
| GO:0046697 | Decidualization | Decreases phenotype | PMID:37482143 |
| GO:0046880 | Regulation of follicle-stimulating hormone secretion | Affects phenotype | PMID:37812459 |
| GO:0046881 | Positive regulation of follicle-stimulating hormone secretion | Increases phenotype | PMID:37364641 |
| GO:0048240 | Sperm capacitation | Increases phenotype | PMID:33711355 |
| GO:0048246 | Macrophage chemotaxis | Increases phenotype | PMID:40323316 |
| GO:0048599 | Oocyte development | Decreases phenotype | PMID:28013214 |
| GO:0048856 | Anatomical structure development | Decreases phenotype | PMID:25353625 |
| GO:0050679 | Positive regulation of epithelial cell proliferation | Increases phenotype | PMID:40323316 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:31199487 |
| GO:0060135 | Maternal process involved in female pregnancy | Decreases phenotype | PMID:30649530 |
| GO:0060305 | Regulation of cell diameter | Affects phenotype | PMID:37021957 |
| GO:0060376 | Positive regulation of mast cell differentiation | Increases phenotype | PMID:37021957 |
| GO:0060467 | Negative regulation of fertilization | Increases phenotype | PMID:30649530 |
| GO:0060512 | Prostate gland morphogenesis | Decreases phenotype | PMID:31199487 |
| GO:0060618 | Nipple development | Affects phenotype | PMID:37788136 |
| GO:0060658 | Nipple morphogenesis | Increases phenotype | PMID:36921846 |
| GO:0061107 | Seminal vesicle development | Decreases phenotype | PMID:30802670; PMID:36921846 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:33983380; PMID:34597818; PMID:36921846 |
| GO:0061458 | Reproductive system development | Decreases phenotype | PMID:37788136 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:35739755 |
| GO:0070662 | Mast cell proliferation | Increases phenotype | PMID:27863430 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:27863430 |
| GO:0071736 | Igg immunoglobulin complex, circulating | Increases phenotype | PMID:28240277 |
| GO:0071743 | Ige immunoglobulin complex, circulating | Increases phenotype | PMID:27863430 |
| GO:0072520 | Seminiferous tubule development | Decreases phenotype | PMID:30802670; PMID:37364641 |
| GO:0090181 | Regulation of cholesterol metabolic process | Affects phenotype | PMID:31577137; PMID:33223173 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:30802670; PMID:33711355 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:31546122 |
| GO:0140354 | Lipid import into cell | Increases phenotype | PMID:35739755; PMID:37927243 |
| GO:0140747 | Regulation of ncrna transcription | Affects phenotype | PMID:37003585 |
| GO:0150175 | Regulation of phosphatidylethanolamine metabolic process | Affects phenotype | PMID:31577137; PMID:33223173 |
| GO:0150178 | Regulation of phosphatidylserine metabolic process | Affects phenotype | PMID:31577137 |
| GO:1900015 | Regulation of cytokine production involved in inflammatory response | Affects phenotype | PMID:38954831 |
| GO:1900017 | Positive regulation of cytokine production involved in inflammatory response | Increases phenotype | PMID:40323316 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Increases phenotype | PMID:24140385 |
| GO:1902884 | Positive regulation of response to oxidative stress | Increases phenotype | PMID:35739755 |
| GO:1902894 | Negative regulation of mirna transcription | Increases phenotype | PMID:37003585 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:29758289; PMID:31423773 |
| GO:1903725 | Regulation of phospholipid metabolic process | Affects phenotype | PMID:33223173 |
| GO:1903786 | Regulation of glutathione biosynthetic process | Affects phenotype | PMID:32949613 |
| GO:1904177 | Regulation of adipose tissue development | Affects phenotype | PMID:37021957 |
| GO:1904598 | Positive regulation of connective tissue replacement involved in inflammatory response wound healing | Increases phenotype | PMID:35739755 |
| GO:1905867 | Epididymis development | Affects phenotype | PMID:30802670; PMID:36921846 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Increases phenotype | PMID:37552060 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:37788136 |
| GO:2000318 | Positive regulation of t-helper 17 type immune response | Increases phenotype | PMID:29758289 |
| GO:2000553 | Positive regulation of t-helper 2 cell cytokine production | Increases phenotype | PMID:29758289 |
| GO:2000786 | Positive regulation of autophagosome assembly | Increases phenotype | PMID:37976928 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:37839492; PMID:39947446 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:37364641 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:37839492 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:34453847; PMID:37364641 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.